about
Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporterCB2 Cannabinoid Receptor As Potential Target against Alzheimer's DiseaseChemical probes of endocannabinoid metabolismCannabinoids as therapeutic agents in cancer: current status and future implicationsEndogenous lipid activated G protein-coupled receptors: emerging structural features from crystallography and molecular dynamics simulationsInteraction between Cannabinoid System and Toll-Like Receptors Controls InflammationEndocannabinoid regulation of β-cell functions: implications for glycaemic control and diabetesThe endocannabinoid system: directing eating behavior and macronutrient metabolismInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionRegulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memoryInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂Anandamide induces sperm release from oviductal epithelia through nitric oxide pathway in bovinesCannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated ratsEndocannabinoid-mediated synaptic plasticity and addiction-related behaviorCannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation.Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy.Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicidesModulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells.Cannabinoid agonists inhibit neuropathic pain induced by brachial plexus avulsion in mice by affecting glial cells and MAP kinases.Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells.CB₁ cannabinoid receptors promote maximal FAK catalytic activity by stimulating cooperative signaling between receptor tyrosine kinases and integrins in neuronal cells.A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence.Endocannabinoid signaling and synaptic function.Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell.Optimization of chemical functionalities of indole-2-carboxamides to improve allosteric parameters for the cannabinoid receptor 1 (CB1).Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effectsCannabinoids inhibit acid-sensing ion channel currents in rat dorsal root ganglion neurons.Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor.Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicalsThe endocannabinoid system and painThe cannabinoid type-1 receptor carboxyl-terminus, more than just a tail.Identification of raloxifene as a novel CB2 inverse agonist.Endocannabinoids in liver disease.Polarized cellular patterns of endocannabinoid production and detection shape cannabinoid signaling in neurons(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)(cyclohexyl)methanone hydrochloride (LDK1229): a new cannabinoid CB1 receptor inverse agonist from the class of benzhydryl piperazine analogs.Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling
P2860
Q24644993-BEB9AEB5-850A-420D-8066-35354775DBC9Q26746050-CDD894F7-7D3A-4C1B-9C35-0F08D1DF456EQ26863202-DEF89856-085D-445B-A95D-650022C82507Q26866298-E4A76582-7695-4A8C-A7C7-2CFF1D680235Q27009220-05FE54BF-E7AE-43DD-8768-6D4682FC3B67Q28066215-456D33FB-A30F-465A-BB5D-8ABD2CB11E48Q28078897-3C13F6F6-3A50-4836-BB6C-0EE8BA38610AQ28086830-2891A249-AE80-4A7F-9C53-DBDDB50BDC52Q28283718-574D0C43-D980-4D17-B1FD-6B16E91933B9Q28295045-C811BFD8-DAB3-403E-9D3E-A3167F4D88E5Q28298445-60C002B8-3B2B-43CC-AEA9-53C0C5B180B3Q28480932-327B79F9-3BDA-4E0F-9DAD-C89B43C44EA6Q28568772-747C63F8-0CAC-4A5F-A111-66EEB1886396Q29042501-F02A7FCF-8E8E-4146-856D-657B4F294C4FQ30661637-EA83AA5C-81EA-4D64-BAFD-2CD839D4AE9DQ33714587-D28469C4-68B4-4175-9B75-DC7148E247ABQ33839407-A92D35F5-6F58-47F2-952E-8EF809497137Q33886361-372967D7-60A9-4D6E-A878-759E64A04BCEQ33923685-27F7A541-5A83-4C4C-BF68-D33A8F1051BEQ34023238-59E376E8-A953-4EED-95B2-0F96A215F327Q34079507-66472C48-3CFD-49FE-93D8-1B1F049A7739Q34194673-E2DDB7EC-724A-4601-8CA4-D5FDF0AB7ACEQ34264449-9C6FC37E-8F6D-4D5C-A8F6-4DC2D2B37615Q34282073-5552616F-873B-4A03-9DEB-9555A162EE00Q34304094-B26AC64F-05C8-42A0-B9D4-5F526EC74188Q34311721-CC6BBAB6-5BA0-4983-8EB7-D537AB4ED0A3Q34359778-110219EB-B540-4066-A5BE-0A98499AF91EQ34372488-F0221492-FBC8-4EEF-A22F-8C5C05832742Q34402180-221E0FD6-6D06-4B3F-9D32-ED6A3ACE0695Q34414372-B6A186C4-C650-4DD3-BCC6-6980EEBD9234Q34429295-B8553DB8-DCEA-4FCD-8DF8-F7219D9F79E5Q34545629-062E2AF8-4EDC-4A14-9F6C-BE71D3487991Q34594647-8E3248F4-9479-455C-AFEB-3FC00B252C34Q34612917-9215F22B-C1EA-4723-94D8-5C557379E40EQ34663357-5B252BA6-AAFA-4E4A-858C-E5464EC9BE0FQ34682833-710608DB-9EE1-4746-B11A-5D3F43879486Q34776919-C3CC13E5-75BD-496D-965B-47DBB5BEAF3DQ34840647-9DCEA2F9-ECC8-4791-97D8-58D465611E3EQ34946743-591AD3DA-0750-47C7-A665-4DBC700383B4Q34953430-E3AB7FE9-36E0-45BE-8A60-FB70950E50DD
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Cannabinoid receptor signaling.
@ast
Cannabinoid receptor signaling.
@en
type
label
Cannabinoid receptor signaling.
@ast
Cannabinoid receptor signaling.
@en
prefLabel
Cannabinoid receptor signaling.
@ast
Cannabinoid receptor signaling.
@en
P356
P1476
Cannabinoid receptor signaling
@en
P2093
A C Howlett
P356
10.1007/3-540-26573-2_2
P577
2005-01-01T00:00:00Z